A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers

Author: Fury Matthew   Zahalsky Andrew   Wong Richard   Venkatraman Ennapadam   Lis Eric   Hann Lucy   Aliff Timothy   Gerald William   Fleisher Martin   Pfister David  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.25, Iss.2, 2007-04, pp. : 165-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content